## Abstract Patients with metastatic melanoma who expressed HLAβCw\*0702 and whose tumors had demonstrable MAGEβA12 expression were immunized with the peptide MAGEβA12:170β178 administered subcutaneously in incomplete Freund's adjuvant (IFA). The peptide was administered either every week or every
Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine
β Scribed by Adam Dangoor; Paul Lorigan; Ulrich Keilholz; Dirk Schadendorf; Adrian Harris; Christian Ottensmeier; John Smyth; Klaus Hoffmann; Richard Anderson; Martin Cripps; Joerg Schneider; Robert Hawkins
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 413 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
K-RAS mutations are frequently found in adenocarcinomas of the pancreas, and induction of immunity against mutant ras can therefore be of possible clinical benefit in patients with pancreatic cancer. We present data from a clinical phase I/II trial involving patients with adenocarcinoma of the pancr
by 40 mg to the MTD in groups of 3 patients. DDP (80 mg/m 2 ) was begun on Day ogy/Oncology, Hollings Cancer Center, Medical 2 and repeated weekly for a total of 3 weeks. During Week 4, the patients were University of South Carolina, Charleston, South not treated with DDP but instead evaluated for r